Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Plus Cisplatin vs EMA-CO in High Risk GTN
NCT02639650Phase 3Recruiting
- Start
- Mar 2016
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, cisplatin in gestational trophoblastic neoplasia (GTN). Started Mar 2016; status: recruiting.
02
Drugs
paclitaxelcisplatin
03
Conditions
gestational trophoblastic neoplasia (GTN)
Beyond the preview
Go deeper on NCT02639650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02639650.